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There were 90 articles published in the Journal of Cardiovascular Magnetic Resonance (JCMR) in 2012, which is an
8% increase in the number of articles since 2011. The quality of the submissions continues to increase. The editors
are delighted to report that the 2011 JCMR Impact Factor (which is published in June 2012) has risen to 4.44, up
from 3.72 for 2010 (as published in June 2011), a 20% increase. The 2011 impact factor means that the JCMR papers
that were published in 2009 and 2010 were cited on average 4.44 times in 2011. The impact factor undergoes
natural variation according to citation rates of papers in the 2 years following publication, and is significantly
influenced by highly cited papers such as official reports. However, the progress of the journal's impact over the last
5 years has been impressive. Our acceptance rate is approximately 25%, and has been falling as the number of
articles being submitted has been increasing. In accordance with Open-Access publishing, the JCMR articles go
on-line as they are accepted with no collating of the articles into sections or special thematic issues. For this reason,
the Editors have felt that it is useful once per calendar year to summarize the papers for the readership into broad
areas of interest or theme, so that areas of interest can be reviewed in a single article in relation to each other and
other recent JCMR articles. The papers are presented in broad themes and set in context with related literature and
previously published JCMR papers to guide continuity of thought in the journal. We hope that you find the
open-access system increases wider reading and citation of your papers, and that you will continue to send your
quality manuscripts to JCMR for publication.Vessel wall & MR angiography
CMR is used widely for research into the vessel wall It
is most frequently used for the carotid arteries where it
characterizes plaque content [1,2], vulnerability, athe-
roma burden, natural history of progression [3], and re-
sponse to treatment [4]. However, imaging of the
coronaries is also making progress. There are fewer re-
ports of coronary luminal imaging, but reports continue
of coronary wall imaging [5,6], and identification of cor-
onary anomalies [7]. This is an area of CMR where 3T
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reproduction in any medium, provided the orQuantitative evaluation of high intensity signal on MIP
images of carotid atherosclerotic plaques from routine
TOF-MRA reveals elevated volumes of intraplaque
hemorrhage and lipid rich necrotic core
High intensity signals in carotid plaques seen on TOF-
MRA MIP images acquired at 3.0 Tesla was shown to be
associated with increased intraplaque haemorrhage and
lipid-rich necrotic core volumes [8]. This is an interes-
ting finding and a simple approach to identify these cli-
nically relevant plaques but the study is limited by poor
sensitivity and the lack of histological validation.Characteristics of carotid atherosclerotic plaques of
chronic lipid apheresis patients as assessed by In vivo
high-resolution CMR - a comparative analysis
Morphology and composition of carotid plaques were
evaluated in patients undergoing chronic lipid apheresis
(LA) who suffered recent stroke using spin-echo images
obtained at 3T [9]. Despite a more severe risk profile forLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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is associated with lower cholesterol, LDL and LDL/HDL
as well as significantly lower lipid content in carotid
plaques compared to plaques of patients without LA with
similar degrees of stenosis. However, the number of pa-
tients studied is small and the study design allows only a
snapshot of plaque burden and composition at one single
time point and no definite conclusions can be drawn on
the evolution of plaque composition over time.
High-resolution intravascular magnetic resonance
quantification of atherosclerotic plaque at 3T
Intravascular CMR using 3T and loopless CMR detector
was used to obtain in vitro and in vivo high resolution
images of atherosclerotic plaques and the findings were
compared with histology [10]. The authors showed that
atherosclerotic lesions in human arterial specimens
in vitro can accurately measure plaque fibrous cap thick-
ness at high-resolution over a range of about 100-
1000μm and that the same approach is feasible in vivo.
Optimization of single shot 3D breath-hold non-enhanced
MR angiography of the renal arteries
Further to previous papers in JCMR on MRA techniques
[11], and multifaceted assessment of the kidneys [12],
Tan et al. describe a single-shot 3D magnetization-
prepared steady-state free precession technique was
implemented to assess the renal arteries and compared
with a more traditional navigator-based approach [13].
The initial results suggest a potential supplementary
clinical role for the breath-hold technique in the evalu-
ation of suspected renal artery diseases.
Detection of thrombus size and protein content by
ex vivo magnetization transfer and diffusion
weighted MRI
Magnetization Transfer Contrast (MTC) and Diffusion
Weighted Imaging (DWI) were used for ex vivo
thrombus imaging at 11.7T. MTC estimated more ac-
curately the thrombus area compared to T1W and T2W
images the rabbit aortic specimens [14]. The quantita-
tive measure of % MTR correlated with the protein
content of the thrombus and allowed the discrimination
between protein-rich (organized) and unorganized
(cell-rich) thrombus. Although application of these
techniques for in vivo thrombus imaging is clinically
relevant but, ex vivo imaging at 11.7 T is of limited clin-
ical interest as results are not transferable to clinical
lower field strengths. Optimization of this work for 3T
has been attempted but is quite weak in this study.
CMR in inflammatory vasculitis
This is a well written and well illustrated review of CMR
in inflammatory vasculitis with an extensive bibliography[15]. As such, this review is a useful reference to clini-
cians from a variety of disciplines.
Cardiovascular magnetic resonance in systemic
hypertension
The authors provide a comprehensive review of the
current and emerging clinical and research applications of
CMR in systemic hypertension which is a highly prevalent
potentially modifiable cardiovascular risk factor [16]. CMR
provides accurate and reproducible measures of ventricu-
lar volumes, mass, function and haemodynamics as well
as uniquely assesses myocardial diffuse and focal fibrosis.
In addition, CMR is well suited for the differential diagno-
sis of LV hypertrophy and the exclusion of common sec-
ondary causes for hypertension.
Pulmonary hypertension
The clinical importance of pulmonary hypertension is be-
ing increasingly recognised and new treatments are being
evaluated. Pulmonary embolism remains a major problem
during in-patient episodes, and evaluation has been im-
proved using computed tomography, although CMR also
shows flow abnormalities which can be useful [17].
Pulmonary endarteretomy normalizes interventricular
dyssynchrony and right ventricular systolic wall stress
Interventricular mechanical dyssynchrony is a mark of
pulmonary hypertension. The authors showed that L-R
dyssynchrony in peak strain recovers to normal values
after pulmonary endarterectomy in patients with chronic
thromboembolic pulmonary hypertension [18]. The RV
end-systolic wall stress plays a key role in this recovery,
reflecting a complex interplay of pulmonary artery pres-
sure, RV radius and wall thickness.
Late gadolinium enhancement cardiovascular magnetic
resonance predicts clinical worsening in patients with
pulmonary hypertension
Late gadolinium enhancement (LGE) occurs at the right
ventricular insertion point in patients with pulmonary
hypertension and has been shown to correlate with CMR
derived RV indices but the prognostic role of LGE is not
well established. This study showed that LGE is a marker
of advanced disease and poor prognosis [19]. RVEF was
also found to be independent non-invasive imaging pre-
dictor of adverse outcomes in this patient population.
Diagnostic accuracy of cardiovascular magnetic
resonance imaging of right ventricular morphology and
function in the assessment of suspected pulmonary
hypertension results from the ASPIRE registry
CMR was shown to be a useful alternative to echocardi-
ography in the evaluation of suspected pulmonary
hypertension [20]. The results of this study supports a
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index, late gadolinium enhancement and the use of
phase contrast imaging in addition to right heart func-
tional indices in patients undergoing diagnostic CMR
evaluation for suspected pulmonary hypertension.
Cardiovascular magnetic resonance in pulmonary
hypertension
This is a comprehensive review of the role of CMR in as-
sessment of patients with pulmonary hypertension [21].
CMR is especially useful in patients with a diagnosis of (or
suspected of having) PAH associated with congenital heart
disease and allows discrimination of other features which
might point to an alternative aetiology. It is a flexible re-
search tool which has opened new avenues for under-
standing treatment effects, outcomes and pathogenesis.
It appears inevitable that its place in the management of
PH will evolve as evidence supporting its use accumulates.
Diffusion tensor imaging
Diffusion tensor imaging (DTI) is an MR technique
which uses diffusion weighting to identify components
of tissue architecture. It has most commonly been ap-
plied to the brain, where larger diffusion values occur
along nerve fibres in comparison to across fibres. This is
interpreted to mean that diffusion occurs more freely
along nerve fibres than between nerve fibres. Spectacular
colour coded images showing the nerve fibre directions
and long distance connections in brain white matter can
be generated. The technique can also be used for the
heart [22], however most work has been done in animals
[23], or in ex-vivo human hearts, because of the high dif-
ficulty of deriving DTI data from the moving heart. Re-
cently a more robust imaging sequence for in-vivo
human cardiac DTI has been described which makes
human studies more approachable [24]. Cardiac DTI
provides information on mean intravoxel myocyte orien-
tation and potentially myocardial disarray, and therefore
first interest has been in investigation of hypertrophic
cardiomyopathy (HCM).
Reproducibility of in-vivo diffusion tensor cardiovascular
magnetic resonance in hypertrophic cardiomyopathy
The authors report the reproducibility of using a
stimulated-echo single-shot-EPI sequence with zonal
excitation and parallel imaging in 10 patients with
HCM scanned on 2 different days [25]. Fractional an-
isotropy (FA), mean diffusivity (MD), and helix angle
(HA) maps were created using a cDTI post-processing
platform developed in-house. The mean ± SD global FA
was 0.613 ± 0.044, MD was 0.750 ±0.154 × 10-3 mm2/s and
HA was epicardium −34.3 ± 7.6°, mesocardium 3.5 ± 6.9°
and endocardium 38.9 ± 8.1°. Comparison of initial and
repeat studies showed global interstudy reproducibility forFA (SD= ± 0.045, Coefficient of Variation (CoV) = 7.2%),
MD (SD = ± 0.135 × 10–3 mm2/s, CoV = 18.6%) and HA
(epicardium SD = ± 4.8°; mesocardium SD = ± 3.4°; endo-
cardium SD = ± 2.9°). Reproducibility of FA was superior
to MD (p = 0.003). Global MD was significantly higher in
the septum than the reference lateral wall (0.784 ± 0.188
vs 0.750 ± 0.154 ×10-3mm2/s, p < 0.001). Septal HA was
significantly lower than the reference lateral wall in all 3
transmural layers (from −8.3° to −10.4°, all p < 0.001). This
is the first study to assess the interstudy reproducibility
of DTI in the human HCM heart in-vivo and the largest
cDTI study in HCM to date. The results showed good
reproducibility of FA, MD and HA which indicates that
current technology yields robust in-vivo measurements
that have potential clinical value. The interpretation of
regional differences in the septum requires further
investigation.
Fiber architecture in remodeled myocardium revealed
with a quantitative diffusion CMR tractography
framework and histological validation
The aim of this study was therefore to develop a technique
for quantitative 3D diffusion CMR tractography of the
heart, and to apply this method to quantify fiber architec-
ture in the remote zone of remodeled hearts [26]. Diffu-
sion Tensor CMR of normal human, sheep, and rat hearts,
as well as infarcted sheep hearts was performed ex vivo. In
normal hearts, the subendocardial and subepicardial
myofibers had a positive and negative HA, respectively,
forming a symmetric distribution around the midmyo-
cardium. However, in the remote zone of the infarcted
hearts, a significant positive shift in HA was observed.
The ratio between negative and positive HA variance was
reduced from 0.96 ± 0.16 in normal hearts to 0.22 < 0.05
in the remote zone of the remodeled hearts (p < 0.05).
This was confirmed histologically by the reduction of HA
in the subepicardium from −52.03° ± 2.94° in normal
hearts to −37.48° ± 4.05° in the remote zone of the remo-
deled hearts (p < 0.05). The authors conclude that there is
a significant reorganization of the 3D fiber continuum in
the remote zone of remodeled hearts. The positive (right-
ward) shift in HA in the remote zone is greatest in the
subepicardium, but involves all layers of the myocardium.
Tractography-based quantification in remodeled hearts
may provide a framework for assessing regional changes
in the left ventricle following infarction.
Congenital heart disease
CMR of congenital heart disease has become relatively
mature, although quality interpretation requires training.
There has been interest in assessing ventricular mechanics
in congenital disease [27], comparing CMR volumetry
with echo [28], defining clinical protocols [29], defining
CMR in congenital disease in children [30], and pregnant
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physiology in these complex patients [32-34]. The use of
4D flow velocity data allows the visualisation of large scale
vorticity and the retrospective measurement of flow in
vessels within the volume covered.
4D cardiovascular magnetic resonance velocity mapping
of alterations of right heart flow patterns and main
pulmonary artery hemodynamics in tetralogy of Fallot
This study using 4D CMR velocity acquisitions studied
flow through the right heart of patients with repaired
tetralogy of Fallot (rTOF) compared with healthy volun-
teers [35]. This technique allows the time courses and
large scale topologies of flow through the cavities to be
compared. Right atrial filling predominantly in diastole
in patients as opposed to systole in volunteers and ab-
normal vortical flow patterns in each right heart cavity
in rTOF were reported. As in other 4D flow studies, ef-
fective averaging of velocities for each cardiac phase
from data acquired over multiple cycles is a limitation,
and the likely presence of multiple variables between in-
dividual patients such as those of cavity geometry, con-
tractile function and valve function, make thorough and
meaningful comparative analysis challenging.
Systemic-to-pulmonary collateral flow in patients with
palliated univentricular heart physiology: measurement
using cardiovascular magnetic resonance 4D velocity
acquisition
In this study, whole-heart 4D velocity acquisitions as well
as five 2D flow acquisitions per study were obtained in pa-
tients with single ventricle physiology, 14 with bidirec-
tional cavopulmonary connection [BCPC], and 15 with
Fontan connections [36]. Good agreement was found be-
tween shunt calculations from the two types of acquisi-
tion, with the 4D approach allowing slightly shorter
acquisition times of about 12 rather than 17 minutes.
Measurements of the amount of shunting and the distri-
butions of flow between the two lungs and between upper
and lower body were documented.
High-resolution motion compensated MRA in patients
with congenital heart disease using extracellular contrast
agent at 3 Tesla
In this study, ECG- and navigator-gated high-resolution
MRA sequence (HR MRA) with slow infusion of extra-
cellular contrast agent was implemented at 3 Tesla for
the assessment of congenital heart disease and compared
to standard first-pass MRA (FP MRA) in 34 patients,
median age 13 years, with congenital heart disease [37].
HR-MRA was found to deliver better image quality com-
pared to FP-MRA and could be integrated into a stand-
ard CMR-protocol for patients with CHD without
additional examination time.Flow
Feasibility of quantification of the distribution of blood
flow in the normal human fetal circulation using CMR: a
cross-sectional study
In this study, CMR phase contrast measurements of flow
were obtained in key parts of circulations of 12 late gesta-
tion human foetuses during late pregnancy [38]. As no
ECG suitable for fetal CMR gating was obtainable, a novel
retrospective gating technique known as metric optimised
gating was used. Measurements of flow recorded included:
combined ventricular output, main pulmonary artery, as-
cending aorta, superior vena cava, ductus arteriosus, pul-
monary branches, descending aorta, umbilical vein and
foramen ovale. These offer novel non-invasive information
on human prenatal circulatory physiology.A multi-center inter-manufacturer study of the temporal
stability of phase-contrast velocity mapping background
offset errors
Measurements of volume flow by phase-contrast velocity
acquisitions can be compromised by background or phase
offset errors [39]. This study assessed the temporal stability
of such errors in 3 different 1.5T CMR systems, GE Signa
Excite, Philips Intera and Siemens Avanto, over 8 weeks
[40]. Retrospectively-gated velocity was acquired with fixed
parameters through a predetermined oblique plane, re-
peated 5 times in rapid succession each week. Temporal
drift in the baseline offset was insignificant on two ma-
chines (0.3 cm/s, 0.2 cm/s), and marginally insignificant on
the third machine (0.5 cm/s) due to an apparent heating
effect. During a typical patient study, background drift was
insignificant, but over a longer timescale of 8 weeks, insig-
nificant drift (0.4 cm/s) occurred on one, with larger drifts
(0.9 cm/s, 0.6 cm/s) on the other 2 systems. This implied
that, while static phantom correction of errors after a scan
and probably after a day of scanning are likely to be effec-
tive, phantom correction after several weeks delay, or cor-
rective calculation based on pre-stored background offset
data, are less likely to be reliable.Velocity encoded cardiovascular magnetic resonance to
assess left atrial appendage emptying
The left atrial appendage (LAA) can be a source of
thrombi that can cause embolic stroke, and impaired
LAA function is thought to predispose to thrombosis.
This study explored the feasibility of assessing LAA
emptying by velocity encoded CMR, comparing it with
trans esophageal echo (TEE) measures, in 18 patients
with sinus rhythm and 12 with atrial fibrillation [41]. It
was concluded that assessment of active and passive
LAA emptying CMR was feasible although further
evaluation would be required for potential applications
such as risk stratification.
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analysis based on ultrahigh temporal resolution
phase-contrast cardiovascular magnetic resonance
Wave intensity analysis, traditionally derived from inva-
sively acquired pressure and velocity data, were here de-
rived from non-invasive CMR measures of velocity and
area from a high-resolution breath hold spiral phase-
contrast acquisition. Ascending and descending aortic
flows were recorded in healthy adult volunteers and
compared with results from 15 patients with coronary
heart disease [42]. Patients had higher wave speed, and
lower forward compression wave and forward expan-
sion wave peaks, which may be attributable to their
older age and reduced aortic compliance as much as to
compromised ventricular function. The semi-automated
analyses were found to be reproducible between ob-
servers, although inter-study reproducibility was not
assessed. The approach shows potential for future non-
invasive investigation of wave intensity in large vessels.
Cardiac output and cardiac index measured with
cardiovascular magnetic resonance in healthy subjects,
elite athletes and patients with congestive heart failure
This study used velocity encoded CMR to establish
whether cardiac index (CI, cardiac output indexed to
body surface area) decreases with age in healthy volun-
teers and compared the CI values of athletes and pa-
tients with congestive heart failure (CHF) [43]. CI was
found to decrease with age, without significant diffe-
rences between males and females in the cohort of 144
volunteers studied. No differences of CI were found be-
tween 60 athletes and the volunteers at rest, but CI was
lower in 157 patients with congestive heart failure.
Aorta
CMR is widely used for assessment of the aorta in both
congenital and acquired conditions and is particularly
well suited for functional of compliance [44], and longi-
tudinal follow-up of aortic dimensions [45]. These pa-
pers continue to expand the value of CMR in this major
artery.
Bramwell-hill modeling for local aortic pulse wave velocity
estimation: a validation study with velocity-encoded
cardiovascular magnetic resonance and invasive
pressure assessment
The Bramwell-Hill model describes the relation be-
tween vascular wall stiffness expressed in aortic dis-
tensibility and the pulse wave velocity (PWV) [46]. In
this study the authors showed that CMR with
velocity-encoding is the optimal approach for study-
ing Bramwell-Hill associations between local PWV
and aortic distensibility [47]. This approach enablesnon-invasive estimation of local pulse pressure and
distensibility.
Normal values of aortic dimensions, distensibility, and
pulse wave velocity in children and young adults: a
cross-sectional study
This study provides normal CMR values for cross-
sectional areas, distensibility and pulse wave velocity of
the thoracic aorta in children and young adolescents and
may serve as a reference for the detection of patho-
logical changes of the aorta [48].
Evaluation of 3D blood flow patterns and wall shear
stress in the normal and dilated thoracic aorta using
flow-sensitive 4D CMR
CMR is being used increasingly to investigate 4D flow
patterns in the heart and great vessels [49]. In this study
flow and vessel wall parameters were investigated in pa-
tients with dilated ascending aorta, age-matched sub-
jects, and healthy volunteers. Increase in ascending
aorta diameter is significantly correlated with the pres-
ence and strength of supra-physiologic-helix and vortex
formation in the ascending aorta, as well with decrease
in systolic regional wall shear stress and increase and
oscillatory shear index [50].
T1 mapping & extracellular volume
T1 mapping is the technique of the moment, and there
has been a large expansion in papers since 2011 pub-
lished on this subject in JCMR [51,52] and other litera-
ture this year.
Extracellular volume fraction mapping in the
myocardium, part 1: evaluation of an automated method
This manuscript describes the development and evalu-
ation of a method of pixel-wise mapping of extra-
cellular volume (ECV) fraction [53]. The method
incorporates a novel approach to motion correction of
a series of inversion recovery images with widely vary-
ing contrasts that is used for the T1-mapping, along
with a new scheme for co-registration of the pre-and
post-contrast T1-maps. The methods were demon-
strated to significantly improve the image quality of
ECV maps and the described implementation which is
fully automated could be simply incorporated into a
clinical workflow.
Extracellular volume fraction mapping in the
myocardium, part 2: initial clinical experience
As a follow up to “Extracellular volume fraction map-
ping in the myocardium, part 1: evaluation of an au-
tomated method" [53], the purpose of Part II was to
provide the “Initial Clinical Experience” and to show
how this method has been feasible in patients, and then
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pothesized that quantitative assessment of myocardial
ECV would be clinically useful for detecting both focal
and diffuse myocardial abnormalities in a variety of com-
mon and uncommon heart diseases. In this preliminary
study they used the method on a total of 156 subjects in-
cluding 62 with normal findings, 33 patients with chronic
myocardial infarction (MI), 33 with hypertrophic cardio-
myopathy (HCM), 15 with non-ischemic dilated cardio-
myopathy (DCM), 7 with acute myocarditis, 4 with
cardiac amyloidosis, and 2 with systemic capillary leak
syndrome (SCLS). Although, due to small numbers, they
cannot prove their hypothesis in this study they do set the
ground work for future larger scale methods using these
improved methods.T1 mapping of the myocardium: Intra-individual
assessment of the effect of field strength, cardiac cycle
and variation by myocardial region
This work investigates the intra-individual variations in
T1 mapping and extracellular volume at different field
strengths, myocardial regions and cardiac phases [55].
The paper probes these important and relevant issues
relating to T1 mapping. The authors’ conclude that
when using the same contrast at equimolar dose, ECV
does not vary with field strength. They also suggest that
the MOLLI measurement shows small changes in myo-
cardial blood volume dependant on the measurement
time within the cardiac cycle. Additionally, minor but
statistically significant differences in ECV between myo-
cardial regions were detected but absolute differences
were small and depending on the application may well
not be relevant.
T1 mapping of the myocardium: intra-individual assess-
ment of post-contrast T1 time evolution and extracellular
volume fraction at 3T for Gd-DTPA and Gd-BOPTA.
This manuscript focuses on the impact of the contrast
agent in the determination of normal ECV and T1
values for healthy volunteers and also assesses stability
of ECV over time [56]. The results showed a minor but
significant difference with contrast agent of 2% between
Gd-DTPA and Gd-BOPTA. The authors’ describe how
the binding of Gd-BOPTA to human serum albumin
will result in a lower molecular tumbling rate of the
molecule and a longer rotational MR correlation time
leading to an increased relaxivity. Also that, since albu-
min is mainly present in blood, the distribution between
blood and myocardium is expected to be different be-
tween Gd-BOPTA and Gd-DTPA. They believe that this
should affect the ratio of the change in relaxation rate
of myocardium and blood and could explain the diffe-
rence in ECV values. The authors also conclude that the
small but significant linear increase in ECV with timeafter a bolus of contrast will necessitate either careful
attention to imaging delay time or post-hoc correction.Comparison of T1 mapping techniques for ECV
quantification. histological validation and reproducibility
of ShMOLLI versus multibreath-hold T1 quantification
equilibrium contrast CMR
In this work, the authors’ introduced the use of a single
breath-hold T1 mapping technique (ShMOLLI) for the
equilibrium contrast method they had initially described
and validated for the measurement of ECV [57]. The re-
sults were compared to the original multi breath-hold IR
technique that they had used previously in healthy vo-
lunteers and patients with HCM, severe aortic stenosis
and amyloid. The study found that all subjects com-
pleted ShMOLLI, whilst a few could not fully complete
the multi breath-hold T1 measurements and there was
good correlation between results from the two tech-
niques, with ShMOLLI achieving slightly higher corre-
lation with histology.Interventional CMR
Direct cooling of the catheter tip increases safety for
CMR-guided electrophysiological procedures
The authors used an EP catheter’s own irrigation system
for cooled-tip ablation and assessed the use of this to re-
duce the temperature at the blood-tissue interface [58].
Initially, in this phantom study the heating was mea-
sured at the catheter tip during typical sequence RF field
exposure in the MR machine. Then using a sophisticated
phantom with temperature sensors located at different
distances from the surface, the ability of the catheter’s
own irrigation system to prevent heating was tested. The
authors’ concluded that the irrigated tip system could be
used to increase MR safety of EP catheters by suppress-
ing the effects of unwanted passive catheter heating due
to RF exposure from the MR scanner.Remote control catheter navigation: options for guidance
under MRI
In this review article a presentation is made of the vari-
ous strategies which have been introduced for remotely
steering vascular catheters within the MRI environment
[59]. Following an introduction covering the potential
advantages and challenges the various methods of cath-
eter location and guidance are reviewed. Remote control
catheter guidance systems were then compared and
contrasted with respect to visualization, safety, and per-
formance. The work concluded that the field was still in
its infancy and that additional experimental studies will
be needed prior to their use in humans.
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probe and providing a distinct tip signal to enhance
clinical safety
In this study the emphasis was again aimed at safety.
The authors’ describe a guide-wire design based on a
loopless antenna [60]. Importantly, they modified this
design by the incorporation a temperature sensor and a
solenoid coil at the tip and then tested the performance
in phantom and in vivo experiments. The detector de-
sign provided good tip visibility for the purpose of de-
vice tracking, and the temperature probe a welcome
safety addition. The authors’ conclude that with this de-
sign we need not rely on prediction to ensure safe clin-
ical operation as future implementations may modulate
specific absorption rate (SAR) based on temperature
feedback.
Towards real-time cardiovascular magnetic resonance
guided transarterial core valve implantation: in vivo
evaluation in swine
The value of CMR in transarterial aortic valve implan-
tation (TAVI) is under exploration [61,62]. In this pre-
clinical study of MRI guided TAVI, the procedure was
performed in 8 swine using the original CoreValve pros-
thesis and a modified, CMR-compatible delivery cath-
eter without ferromagnetic components [63]. Due to
the recent success of TAVI the topic is timely and the
study illustrates nicely the technical progress in delivery
systems, devices and real time (rt) CMR imaging tech-
niques. Owing to the unlimited scan plane orientation
and an unsurpassed soft-tissue contrast with simultan-
eous device visualization, rtCMR is presumed to allow
safe device navigation and to offer optimal orientation
for precise axial positioning. This work demonstrated
the feasibility of rtCMR-guided TAVI using the nitinol-
based CoreValve bioprosthesis.
Cardiomyopathy
The phenotyping of cardiomyopathy is a major success
story for CMR, and has led to gene discovery [64], and
identification of subtle myocardial mechanical derange-
ment [65]. CMR has made recent advances in unusual
conditions such as wet beri-beri [66], takotsubo cardio-
myopathy [67], lamin A/C dilated cardiomyopathy [68],
limb girdle muscular dystrophy [69], Duchenne muscu-
lar dystrophy [70-72].
The diagnosis of hypertrophic cardiomyopathy by
cardiovascular magnetic resonance
Hypertrophic cardiomyopathy (HCM) is characterised by
asymmetric hypertrophy, increased fibrosis and myocyte
disarray. It represents the most common genetic disorder
of the myocardium. There is a wide range of clinical ex-
pression, ranging from asymptomatic mutation carriers[73], to sudden cardiac death as the first manifestation
of the disease. In spite of advances in genotyping, the
spectrum of phenotype is wide. CMR is increasingly
used to characterize morphologic, functional and tissue
abnormalities associated with HCM. CMR appears to be
highly relevant in the clinical as well as research evalu-
ation of patients with overt as well as pre-clinical HCM.
Late enhancement after gadolinium administration al-
lows tissue characterization of myocardial fibrosis. It is
present in approximately 60% of HCM patients with
LVH. The method may potentially identify HCM pa-
tients at greatest risk for adverse cardiac events. CMR
evaluation of HCM mutation carriers in an early stage
of disease has yet to be extensively evaluated, but repre-
sents a promising method for exploring the inter-
relationship between functional, morphologic and tissue
abnormalities in HCM. This review assesses the role of
CMR in characterising the current and future roles of
CMR in HCM [74].Clinical utility of cardiovascular magnetic resonance in
hypertrophic cardiomyopathy
In this review article, Maron considers the incremental
role of CMR in patients with HCM [75]. Complemen-
ting the separate review by Radwa et al., in this article
the role of CMR in high-risk HCM patient subgroups is
discussed including those with thin-walled scarred LV
apical aneurysms, end-stage systolic dysfunction, and
massive LV hypertrophy. CMR observations to include
thickening of the right ventricular wall as well as sub-
stantial morphologic diversity with regard to papillary
muscles and mitral valve are discussed. The implica-
tions for management strategies in patients undergoing
invasive septal reduction therapy is considered. Among
HCM family members, CMR has identified unique
phenotypic markers of affected genetic status in the ab-
sence of LV hypertrophy including: myocardial crypts,
elongated mitral valve leaflets and late gadolinium en-
hancement. Understanding the prognostic significance
of fibrosis is assessed. The clinical role of contemporary
CMR in management is considered in this timely review
article.Diagnostic and prognostic value of cardiovascular
magnetic resonance in non-ischaemic cardiomyopathies
In this review, the current evidence base to support the
role of CMR in the evaluation of cardiomyopathies is
discussed [76]. The unique strength of CMR relates to
the range of tissue characterisation and sequences avail-
able. Applications of this are well established in the diag-
nosis of cardiomyopathies and increasingly in directing
therapy and guiding prognostic evaluation.
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cardiomyopathy can be identified by cardiovascular
magnetic resonance, and is associated with left
ventricular diastolic dysfunction
This study was undertaken to detect and quantify diffuse
myocardial fibrosis HCM patients using a histologically va-
lidated CMR post-contrast myocardial T1 mapping tech-
nique [77]. Furthermore, they investigated the relationships
of both patterns of fibrosis to LV diastolic performance and
clinical manifestations. This study demonstrated that pa-
tients with HCM have reduced post-contrast myocardial
T1 times, consistent with the presence of diffuse interstitial
fibrosis. Furthermore, the independent association of post-
contrast myocardial T1 time with estimated LV filling pres-
sure (E/e’) suggests a mechanistic link between altered
myocardial composition and function. The non-invasive
detection of diffuse fibrosis, in combination with standard
LGE sequences to identify dense regional fibrosis, could
allow a detailed evaluation of patterns of fibrosis in HCM.
Further research utilizing this technique may enhance un-
derstanding of the relationships between HCM genetic mu-
tations, abnormal myocardial structure and function, and
risk stratification and may facilitate the future development
of disease-modifying therapies.
Myocardial scarring on cardiovascular magnetic
resonance in asymptomatic or minimally symptomatic
patients with “pure” apical hypertrophic cardiomyopathy
In this study, the authors found that myocardial fibrosis is
seen in about 75% of patients with asymptomatic or mildly
symptomatic ‘pure’ apical HCM patients [78]. They ob-
served that apical segments, including apical cap, were the
most frequently involved LGE sites in apical HCM pa-
tients. LGE was not limited to hypertrophic apical seg-
ments, and that it was also present in basal segments, at
the anterior and posterior junctions between the septum
and RV free wall, and additionally in non-hypertrophied
segments of apical HCM. Importantly, LGE observed at
apex (including apical cap) 48% of 97 apical segments
showing LGE was in a “subendocardial” pattern, quite un-
like the patchy or focal mid-wall LGE pattern frequently
observed in asymmetrical septal HCM patients. Given that
“ischemic-type” LGE is usually characterized by suben-
docardial involvement with or without extension into
subepicardium, the subendocardial LGE pattern at apex in
their population suggests previous subendocardial ische-
mia. This “ischemic-type” LGE is likely to be attributable
to mechanisms other than epicardial coronary stenosis. A
hypertrophied apical wall with relatively deficient coronary
blood flow may be a plausible explanation for this “ische-
mic-type” LGE. However, an increment in intra-apical
cavitary pressure that might subsequently lead to subopti-
mal perfusion to the subendocardial area could explain
“ischemic-type” LGE at the apex, as well. It is unclear ifthese patterns are representative of adverse prognosis in
this asymptomatic or minimally symptomatic apical HCM
population, especially in the short term.The protein binding substance ibuprofen does not affect
the T1 time or partition coefficient in contrast-enhanced
cardiovascular magnetic resonance
In this study, the authors assessed the effect of co-
medication with a typical protein binding drug (Ibuprofen)
on contrast enhanced T1 mapping [79]. The authors con-
sider the most important findings can be summarized as
follows: 1.) Ibuprofen did not significantly affect T1 times
of myocardium and blood when using a gadolinium based
contrast agent with protein binding capacity (Gd-BOPTA)
2.) Correlations of T1 times of myocardium and blood
and partition coefficient between exam 1 and 2 were ex-
cellent reflecting good reproducibility.Structural and functional cardiac changes in myotonic
dystrophy type 1: a cardiovascular magnetic resonance
study
Myotonic dystrophy type 1 (MD1) is a neuromuscular dis-
order with potential involvement of the heart and in-
creased risk of sudden death. It is an autosomal dominant
inherited disorder caused by an unstable expansion of a
repetitive trinucleotide sequence (CTG) on chromosome
19. The prevalence varies from 2.1-14.3 per 100 000. MD1
is characterized by slowly progressive weakness of skeletal
muscles, myotonia and involvement of several organ sys-
tems. An earlier age of onset and increased severity of
clinical symptoms has been observed in subsequent gener-
ations and is related to degree of CTG expansion. Patients
with MD1 usually die from respiratory or cardiac compli-
cations. Sudden death is considered to be the result of
atrioventricular block or ventricular arrhythmias. Recent
studies showed that severe electrocardiographic (ECG) ab-
normalities and atrial arrhythmias are independent risk
factors, although with moderate sensitivity, for sudden
death in MD1 patients. Although death from progressive
heart failure is uncommon in patients with MD1 com-
pared to other muscular dystrophies, left ventricular sys-
tolic dysfunction is associated with an increased risk of
overall mortality and sudden death. Therefore, the picture
emerges that MD1 patients have a complex cardiac
phenotype including both the myocardium and the con-
duction system. The principal finding of this study is that
structural and functional myocardial abnormalities are fre-
quent in MD1 patients [80]. The presence of mild to mod-
erate left ventricular systolic dysfunction, ventricular
dilatation, myocardial hypertrophy or fibrosis was strongly
associated with electrocardiographic conduction abnor-
malities. However, 16% of patients with a normal ECG still
had myocardial alterations. These findings lend support to
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the pathogenic process of MD1.
Diffuse myocardial fibrosis evaluation using cardiac
magnetic resonance T1 mapping: sample size
considerations for clinical trials
The aim of this study was to determine the reproducibil-
ity and sample size of CMR fibrosis measurements that
would be applicable in clinical trials [81]. Mean ECV
and λ were both significantly higher in HF subjects than
healthy (ECV: 0.287 ± 0.034 vs. 0.267 ± 0.028, p = 0.002;
λ: 0.481 ± 0.052 vs. 442 ± 0.037, p < 0.001, respectively).
The inter-study ECV and λ variation were about 2.8
times greater than the intra-study ECV and λ variation
in healthy subjects (ECV: 0.017 vs. 0.006, λ: 0.025 vs.
0.009, respectively). The estimated sample size to detect
ECV change of 0.038 or λ change of 0.063 (correspond-
ing to ~3% increase of histological myocardial fibrosis)
with a power of 80% and an alpha error of 0.05 for heart
failure subjects using a two group design was 27 in each
group, respectively. ECV and partition coefficient have a
relatively low variability for repeat scans, and could be a
viable tool for evaluating clinical trial outcome. Sample
size estimation showed that a study with 27 participants
in each group could detect a 0.038 change in ECV or
0.063 change in partition coefficient with 80% of power,
which corresponding to about 3% increase in histological
collagen tissue. ECV and λ quantification have a low
variability across scans, and could be a viable tool for
evaluating clinical trial outcome.
The impact of repeated marathon running on
cardiovascular function in the aging population
Participation in strenuous aerobic physical activity is in-
creasing among the aging population. The cardiovascular
effects of acute strenuous exercise, specifically marathon
running, have demonstrated a transient increase in cardiac
biomarkers and right ventricular (RV) systolic dysfunction
using multimodality cardiac imaging, including transtho-
racic echocardiography (TTE) and cardiovascular mag-
netic resonance (CMR). Little is known, however, on the
cardiovascular effects of repeated marathon running in in-
dividuals over the age of 50. The aims of the current study
were two-fold: 1) To assess the extent and severity of car-
diac dysfunction after the completion of full marathon
running in elite individuals >50 years of age using cardiac
biomarkers, TTE and CMR; and 2) If there is evidence of
LGE on CMR, to detect the presence of silent coronary ar-
tery disease using cardiac computed tomography (CCT)
[82]. Marathon running in individuals over the age of 50 is
associated with a transient, yet reversible increase in car-
diac biomarkers and RV systolic dysfunction. The presence
of myocardial fibrosis in older marathon athletes is infre-
quent, but when present, may be due to underlying occultcoronary artery disease. Larger studies are needed to con-
firm these findings.
Effects of combined deferiprone with deferoxamine on
right ventricular function in thalassaemia major
With the development of the T2* technique [83], and the
black-blood sequence [84], CMR has provided new in-
sights into iron-overload cardiomyopathy, as the myocar-
dial iron concentration [85], prognosis [86], and its toxic
effect on ventricular function [87], can be assessed at the
same time with the same high-fidelity technique. Recent
advances include identification of the lack of myocardial
fibrosis [88], the involvement of the right ventricle [89],
early strain abnormalities [90], and improved prognosis
[91]. Combination therapy with deferoxamine and oral
deferiprone is superior to deferoxamine alone in removing
cardiac iron and improving left ventricular ejection frac-
tion (LVEF). The right ventricle (RV) is also affected by
the toxic effects of iron and may cause additional cardio-
vascular perturbation. In this study, the authors assessed
the effects of combination therapy on the RV in thalassae-
mia major (TM) using CMR [92]. In the RCT, com-
bination therapy with deferoxamine and deferiprone
was superior to deferoxamine alone for improving RVEF
(3.6 vs 0.7%, p = 0.02). The increase in RVEF was greater
with lower baseline T2* 8–12 ms (4.7 vs 0.5%, p = 0.01)
than with T2* 12–20 ms (2.2 vs 0.8%, p = 0.47). In patients
with severe cardiac siderosis, substantial improvement in
RVEF was seen with open-label combination therapy
(10.5% ± 5.6%, p < 0.01). Adding deferiprone to defero-
xamine has beneficial effects on both RV and LV function
in TM patients with cardiac siderosis.
Cardiovascular magnetic resonance findings in a pediatric
population with isolated left ventricular non-compaction
Several echocardiographic and CMR measurements have
been proposed to diagnose LVNC. There has been an as-
sociation between adult patients with isolated LVNC and
depressed left ventricular function; however the reason for
this remains unclear. In adults, it has been found that
some of these measurements such as NC/C ratio and
NCMA are well correlated with systolic dysfunction. How-
ever, in children these relations have not been yet
established. In this study the authors investigated the rela-
tion between different anatomical measurements with
ventricular performance using CMR in a pediatric popula-
tion [93]. They found that only five patients had a
decreased EF (< 53%) and that there was a poor correl-
ation between EF and measurements such as CMM,
CMA, NC/C ratio and the X:Y ratio proposed by Chin
et al. A better correlation was found between EF and
NCMA (R = 0.67). In this study the NCMA was calculated
as the sum of the NCMA on LA and 4Ch views; this was
done to include any septal and lateral walls that may
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non-compaction in children was similar to published adult
data with a predilection for apical, mid-inferior and mid-
lateral segments. Five patients had systolic dysfunction
with decreased EF. The number of affected segments was
the strongest predictor of systolic dysfunction, all five pa-
tients had greater than 9 affected segments. Basal seg-
ments were less commonly affected but they were affected
only in these five severe cases. The segmental pattern of
involvement of non-compaction in children is similar to
that seen in adults. Systolic dysfunction in children is
closely related to the number of affected segments.
Valves
The application of CMR to the assessment of valvular
heart disease continues to increase, notably with respect
to aortic stenosis [94]. This is in part due to greater ap-
preciation of its capability, wider accessibility, and an
expanding scientific literature.
Heart valve disease: investigation by cardiovascular
magnetic resonance
This excellent review summarises and discusses the addi-
tive value of CMR in the investigation of valve disease,
highlighting not only its many advantages as an adjunct to
echocardiography, but addressing also the limitations of
the technique [95]. The ability to image in any plane, fa-
cilitating direct measurement of valve area, and the ability
to accurately quantify flow are strengths of this technique.
In combination with the unparalleled and established ac-
curacy of CMR in quantifying ventricular volumes and
mass, the technique offers evaluation not only of the valve,
but also the sequelae of the disease on the heart. This is
not withstanding the additional information offered by the
administration of Gadolinium contrast. Acknowledgment
is made of the limitations imposed by image slice thick-
ness with respect to partial volume effects, the potential
underestimation of aortic regurgitation due to through
plane motion of the aortic root, and also the limited ability
to identify small highly mobile objects as a consequence of
acquiring images over several cardiac cycles. The review
considers the optimal imaging of each valve and empha-
sises the increasingly prominent role of CMR in investigat-
ing the pulmonary valve and right ventricle.
Left ventricular remodeling and hypertrophy in patients
with aortic stenosis: insights from cardiovascular
magnetic resonance
This manuscript describes the novel application of CMR
quantification of indexed left ventricular volumes and
mass index to investigate and characterise the impact of
the pressure loading in aortic stenosis on left ventricular
remodelling and hypertrophy in 91 patients with echo-
cardiographic moderate or severe aortic stenosis [96].There was no significant correlation between the degree
of hypertrophy (r2 = 0.012, P = 043), adaptive response of
the ventricle (P = 0.22) and the severity of aortic stenosis
as assessed by CMR. Although concentric hypertrophy
was the most commonly observed response (n = 34, 37%
of patients), six patterns of LV adaptation were observed.
Asymmetric patterns of wall thickening were frequently
noted (n = 14) with some phenotypic overlap with hyper-
trophic cardiomyopathy.
Cardiovascular magnetic resonance evaluation of aortic
stenosis severity using single plane measurement of
effective orifice area
Further consideration of the utility of CMR in the assess-
ment of aortic stenosis is made in this study seeking to
validate novel CMR estimation of valve effective orifice
area (EOA) by a single plane method using jet shear layer
detection (JSLD) against CMR estimation of EOA by the
continuity equation and the customary echocardiographic
measure of EOA by the continuity equation [97]. JSLD
and the simplified JSLD method assessed are based on the
acoustical source term (AST) concept which interrogates
the source of the acoustic noise created by the accelerated
flow beyond the stenotic valve. In vitro assessment of the
CMR technique agreed well with theoretical prediction, in
addition to in vivo study in 8 healthy volunteers and 37
patients across the spectrum of severity of aortic stenosis.
CMR estimation of EOA by both the novel methods
(r = 0.93) and continuity equation (r = 0.88) all agreed well
with EOA estimation by TTE, supporting use of CMR,
especially where echocardiography is suboptimal or incon-
clusive. Reproducibility was favourable for CMR compared
to echocardiography regardless of method.
Myocardial perfusion
Although myocardial perfusion CMR has been possible
for many years, the clinical sequence and data process-
ing remain variable between centres. The papers below
help to close the gap between research and clinical prac-
tice including reports from the large MR-INFORM and
the MR-IMPACT trials. Recent developments in acceler-
ated acquisitions, quantification perfusion acquisition
techniques [98], and even new contrast agents [99], will
feed into clinical practice in due course.
Design and rationale of the MR-INFORM study: stress
perfusion cardiovascular magnetic resonance imaging to
guide the management of patients with stable coronary
artery disease
In patients with stable coronary artery disease (CAD),
decisions regarding revascularisation are primarily
driven by the severity and extent of coronary luminal
stenoses as determined by invasive coronary angiog-
raphy. More recently, revascularisation decisions based
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proved event free survival. Perfusion CMR has been
shown to be non-inferior to nuclear perfusion imaging in
a multi-centre setting and superior in a single centre trial.
In addition, it is similar to invasively determined FFR and
therefore has the potential to become the non-invasive
test of choice to determine need for revascularisation. This
paper describes the rationale and study protocol for the
MR-INFORM trial comparing MR and FFR [100]. The
MR-INFORM study is a prospective, multi-centre, rando-
mised controlled non-inferiority, outcome trial. The ob-
jective is to compare the efficacy of two investigative
strategies for the management of patients with suspected
CAD. Patients presenting with stable angina are rando-
mised into two groups: 1) The FFR-INFORMED group has
subsequent management decisions guided by coronary
angiography and fractional flow reserve measurements. 2)
The MR-INFORMED group has decisions guided by stress
perfusion CMR. The primary end-point will be the occur-
rence of major adverse cardiac events (death, myocardial
infarction and repeat revascularisation) at one year. MR IN-
FORM will assess whether an initial strategy of perfusion
CMR is non-inferior to invasive angiography supplemented
by FFR measurements to guide the management of patients
with stable coronary artery disease. Non-inferiority of per-
fusion CMR to the current invasive reference standard of
FFR would establish perfusion CMR as an attractive non-
invasive alternative to current diagnostic pathways.
Superior diagnostic performance of perfusion-
cardiovascular magnetic resonance versus SPECT to
detect coronary artery disease: The secondary endpoints
of the multicenter multivendor MR-IMPACT II (Magnetic
Resonance Imaging for Myocardial Perfusion Assessment
in Coronary Artery Disease Trial).
Perfusion-cardiovascular magnetic resonance (CMR) is
generally accepted as an alternative to SPECT to assess
myocardial ischemia non-invasively. However its perform-
ance vs gated-SPECT and in sub-populations is not fully
established. In this multicenter study, the diagnostic per-
formance of perfusion-CMR and gated-SPECT was com-
pared for the detection of CAD in various populations
using conventional x-ray coronary angiography (CXA) as
the standard of reference [101]. In 33 US and Europe cen-
ters, 533 patients were enrolled in this multivendor trial.
SPECT and CXA were performed within 4 weeks before
or after CMR in all patients. Prevalence of CAD in the
sample was 49% and 515 patients received MR contrast
medium. Drop-out rates for CMR and SPECT were 5.6%
and 3.7%, respectively (ns). The study was powered for the
primary endpoint of non-inferiority of CMR vs SPECT for
both, sensitivity and specificity for the detection of CAD
(using a single-threshold reading). The results for the pri-
mary endpoint were reported elsewhere, and in this article
the secondary endpoints of diagnostic performance ofCMR versus SPECT in subpopulations such as multi-
vessel disease (MVD), in men, in women, and in patients
without prior myocardial infarction (MI) are presented.
The diagnostic performance (= area under ROC = AUC)
of CMR was superior to SPECT (p = 0.0004, n = 425) and
to gated-SPECT (p = 0.018, n = 253). CMR performed bet-
ter than SPECT in MVD (p = 0.003 vs all SPECT, p = 0.04
vs gated-SPECT), in men (p = 0.004, n = 313) and in
women (p = 0.03, n = 112) as well as in the non-infarct
patients (p = 0.005, n = 186 in 1–3 vessel disease and
p = 0.015, n = 140 in MVD). The authors conclude that
the diagnostic performance of perfusion-CMR to detect
CAD was superior to perfusion SPECT in the entire popu-
lation and in sub-groups. Perfusion-CMR can be reco-
mmended as an alternative for SPECT.
Comparison of exercise electrocardiography and stress
perfusion CMR for the detection of coronary artery
disease in women
Exercise electrocardiography (ECG) is frequently used in
the work-up of patients with suspected coronary artery dis-
ease (CAD), however the accuracy is reduced in women.
CMR stress testing can accurately diagnose CAD in
women. This study reports a direct comparison of CMR to
ECG [102]. The authors prospectively enrolled 88 consecu-
tive women with chest pain or other symptoms suggestive
of CAD. Patients underwent a comprehensive clinical
evaluation, exercise ECG, perfusion CMR and infarct im-
aging, and x-ray coronary angiography (CA) within 24
hours. CAD was defined as stenosis ≥70% on quantitative
analysis of CA. Exercise ECG, CMR and CA was com-
pleted in 68 females (age 66.4 ± 8.8 years, number of CAD
risk factors 3.5 ± 1.4). The prevalence of CAD on CA was
29%. The Duke treadmill score (DTS) in the entire group
was −3.0 ± 5.4 and was similar in those with and without
CAD (−4.5 ± 5.8 and −2.4 ± 5.1; P = 0.12). Sensitivity, spe-
cificity and accuracy for CAD diagnosis was higher for
CMR compared with exercise ECG (sensitivities 85% and
50%, P = 0.02, specificities 94% and 73%, P = 0.01, and ac-
curacies 91% and 66%, P = 0.0007, respectively). Even after
applying the DTS the accuracy of CMR was higher com-
pared to exercise ECG (area under ROC curve 0.94 ± 0.03
vs 0.56 ± 0.07; P = 0.0001). The authors conclude that in
women with intermediate-to-high risk for CAD who are
able to exercise and have interpretable resting ECG, perfu-
sion CMR has higher accuracy for the detection of rele-
vant obstruction of the epicardial coronaries than the
exercise ECG.
Considerations when measuring myocardial perfusion
reserve by cardiovascular magnetic resonance using
regadenoson
Adenosine perfusion CMR can quantify myocardial perfu-
sion reserve. While regadenoson is increasingly employed
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standardized. The authors sought to determine the opti-
mal regadenoson CMR protocol for quantifying myo-
cardial perfusion reserve index (MPRi), and whether
regadenoson stress imaging should be performed before
or after rest imaging [103]. Twenty healthy subjects
underwent CMR perfusion imaging during resting condi-
tions, during regadenoson-induced hyperemia (0.4 mg),
and after 15 min of recovery. In 10/20 subjects, recovery
was facilitated with aminophylline (125 mg). Myocardial
time-intensity curves were used to obtain left ventricular
cavity-normalized myocardial up-slopes. MPRi was calcu-
lated in two different ways: as the up-slope ratio of stress to
rest (MPRi-rest), and the up-slope ratio of stress to recovery
(MPRi-recov). In all 20 subjects, MPRi-rest was 1.78 ± 0.60.
Recovery up-slope did not return to resting levels, regard-
less of aminophylline use. Among patients not receiving
aminophylline, MPRi-recov was 36 ± 16% lower than
MPRi-rest (1.13 ± 0.38 vs. 1.82 ± 0.73, P = 0.001). In the
10 patients whose recovery was facilitated with aminoph-
ylline, MPRi-recov was 20 ± 24% lower than MPRi-rest
(1.40 ± 0.35 vs. 1.73 ± 0.43, P = 0.04), indicating incom-
plete reversal. In 3 subjects not receiving aminophylline
and 4 subjects receiving aminophylline, up-slope at reco-
very was greater than at stress, suggesting delayed maximal
hyperemia. The authors conclude that MPRi measurements
from regadenoson CMR are underestimated if recovery
perfusion is used as a substitute for resting perfusion, even
when recovery is facilitated with aminophylline.
Myocardial first-pass perfusion imaging with hybrid-EPI:
frequency-offsets and potential artefacts
First-pass myocardial perfusion is often imaged with a tai-
lored hybrid centric interleaved echo-planar-imaging se-
quence, providing rapid image acquisition with good
contrast enhancement. The centric interleaved phase-
encode order minimises the effective time-of-echo but it is
sensitive to frequency-offsets. This article aims to show
possible artefacts that might originate with this sequence,
in the context of first-pass perfusion imaging, when
frequency-offsets are present [104]. Numerical and phan-
tom simulations were used to illustrate the effects of
frequency-offsets and non-uniform magnitude modulation
with this sequence in a typical perfusion protocol. In vivo
data was post-processed to analyse the h-EPI’s sensitivity
to the frequency-offsets. The centric phase-order was
shown to be highly sensitive to frequency-offsets due to its
symmetrical phase slope. Resulting artefacts include blur-
ring, and splitting of the image into two identical copies
along the phase-encode direction. It was also shown that
frequency-offsets can introduce signal loss and ghosting of
the right ventricle signal into the myocardium. The in vivo
results were confirmed by numerical and phantom simula-
tions. Magnitude modulation effects were found to besmall. The authors conclude that imaging first-pass myo-
cardial perfusion with an hybrid centric echo-planar-im-
aging sequence can be corrupted with ghosting and
splitting of the image due to frequency-offsets.
Perfusion cardiovascular magnetic resonance: comparison
of an advanced, high-resolution and a standard sequence
Technical advances in perfusion CMR, particularly accel-
erated data acquisition methods, allow myocardial perfu-
sion imaging with unprecedented spatial resolution.
However, it is not clear how implementation of these re-
cent advances affects perfusion image quality, signal and
contrast to noise ratios (SNR & CNR) and the occurrence
of important artefacts in routine clinical imaging. The ob-
jective of this study was therefore to compare a standard
and an advanced, high-resolution perfusion sequence
[105]. A standard ultrafast gradient echo perfusion
sequence (st-GrE) was compared with an advanced
kt-accelerated steady state free precession sequence
(ktBLAST-SSFP) at 1.5 T in healthy volunteers (n = 16)
and in patients (n = 32) with known or suspected coronary
artery disease. Volunteers were imaged with both se-
quences at rest and patients underwent stress and rest im-
aging with either st-GrE or ktBLAST-SSFP prior to X-ray
coronary angiography. In normal hearts ktBLAST-SSFP
imaging resulted in significantly improved image quality
(p = 0.003), SNR (21.0 ± 6.7 vs. 18.8 ± 6.6; p = 0.009),
CNR (15.4 ± 6.1 vs. 14.0 ± 6.0; p = 0.034) and a reduced
extent (p = <0.0001) and transmurality (p = 0.0001) of
DRA. In patients ktBLAST-SSFP imaging resulted in sig-
nificantly improved image quality (p = 0.012), and a re-
duced extent (p = <0.0001), duration (p = 0.004) and
transmurality (p = <0.0001) of DRA. Sensitivity and speci-
ficity for the detection of CAD against X-ray angiography
was comparable with both sequences. There was a non-
significant trend towards increased respiratory artefacts
with ktBLAST-SSFP in both patients and volunteers. The
authors conclude that advanced high resolution perfusion
CMR using a k-t-accelerated SSFP technique results in
significantly improved image quality, SNR and CNR and a
reduction in the extent and transmurality of DRA com-
pared to a standard sequence. These findings support the
use of advanced perfusion sequences for clinical perfusion
imaging however further studies exploring whether this
results in improved diagnostic accuracy are required.
Quantitative myocardial perfusion in mice based on the
signal intensity of flow sensitized CMR
In the conventional approach to arterial spin labeling in
the rodent heart, the relative difference in the apparent
T1 relaxation times corresponding to selective and non-
selective inversion is related to perfusion via a two com-
partment model of tissue. But accurate determination of
T1 in small animal hearts is difficult and prone to errors
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study, the authors introduce the theoretical frame work
for an alternative method based on the signal intensity
of slice-select and non-select inversion recovery images
at a single inversion time at short repetition time [106].
A modified Bloch equation was solved to derive perfu-
sion as a function of signal intensity of flow sensitized
segmented gradient echo acquisitions. A 2 compartment
fast exchanging model of tissue was assumed. To test
the new technique first it was implemented on a flow
phantom and then it was compared with the conven-
tional T1 method in an in vivo study of healthy C57BL/
6 mice (n = 12). Finally the SI-method was used in com-
parison to a Late Gadolinium Enhanced (LGE) method
to qualitatively and quantitatively assess perfusion defi-
cits in an ischemia-reperfusion mouse model (n = 4). The
myocardial perfusion of healthy mice obtained by the SI-
method, 5.6 ± 0.5 ml/g/min, (mean ± standard deviation)
was similar (p = 0.38) to that obtained by the conventional
method, 5.6 ± 0.3 ml/g/min. The variance in perfusion
within the left ventricle was less for the SI-method than
that for the conventional method (p < 0.0001). The LGE
regions of the ischemia reperfusion model were matched
with regions of hypo-perfusion in the perfusion map. The
average perfusion in the hypoperfused region among all 4
IR mice was 1.2 ± 0.9ml/g/min and that of the remote re-
gion was 4.4 ± 1.2ml/g/min. The proposed signal intensity
based ASL method with a segmented acquisition scheme
allows accurate high resolution perfusion mapping in
small animals. It’s short scan time, high reproducibility
and ease of post process makes it a robust alternative
to the conventional ASL technique that relies on T1
measurements.
Acute and chronic coronary artery disease
CMR is invaluable to the study of patients with ischae-
mic heart disease and has made a major impact on this
field since the first reports of inversion-recovery tech-
niques to delineate myocardial infarction. The use of
CMR in the acute cardiac setting has been reviewed
[107], and recent application has also been reported in
improving understanding of the behaviour of the heart
during ventricular fibrillation [108], and response to
stem cell treatment [109]. In the acute setting, the value
of myocardial perfusion has been reported [110,111], as
well as assessment of salvage [112]. The role of CMR in
the chronic setting of coronary disease has been exten-
sively studied. The prevalence of infarction in heart fail-
ure [113], and data on the prediction of predicting
revascularization improvement in function was recently
reported [114]. In known or suspected coronary artery
disease, there has been a review of dobutamine stress
CMR [115], and data on the prognosis of myocardial scar
in patients with normal wall motion [116], as well as astudy of the role of ischemic preconditioning [117]. There
have also been reports of new techniques in animals
[118-120]. The papers below show how CMR can be used
in a number of ways to characterize acute infarction.
Prognostic value at 5 years of microvascular obstruction
after acute myocardial infarction assessed by
cardiovascular magnetic resonance
Microvascular obstruction (MVO) or the ‘no-reflow’
phenomenon is an established complication of coronary
reperfusion therapy for acute myocardial infarction. It is
increasingly recognized as a poor prognostic indicator and
marker of subsequent adverse LV remodeling. Klug
reported the relation between microvascular obstruction
(MVO) on first-pass gadolinium images and outcomes in
129 patients treated with primary angioplasty for ST-
segment elevation myocardial infarction (STEMI) [121].
At a median follow-up of 52 months, 63 pre-defined end-
points (a composite of death, myocardial re-infarction,
stroke, repeat revascularization, recurrence of ischemic
symptoms, atrial fibrillation, congestive heart failure and
hospitalization) had occurred. The primary endpoint oc-
curred in 66.2% of patients with and 42.4% of patients
without MVO (p < 0.05). The presence of early MVO was
associated with worse event-free survival and was the
strongest independent predictor for the occurrence of the
primary endpoint in a multivariable Cox regression ana-
lysis adjusting for age, ejection fraction and infarct size
(hazard ratio: 2.79, 95%-CI 1.25-6.25, p = 0.012). Patients
with early MVO also had larger infarcts and a lower EF.
Although other studies have shown that MVO is a prog-
nostic marker for clinical endpoints [122], the follow-up
has previously only been relatively short-term and this
study was able to confirm early MVO as an independent
long-term prognosticator for morbidity after acute myo-
cardial infarction.
Assessment of intramyocardial hemorrhage by
T1-weighted cardiovascular magnetic resonance in
reperfused acute myocardial infarction
Due to their inherent susceptibility to field inhomogeneity,
T2* sequences have been used to assess intramyocardial
hemorrhage (IMH) [123]. The methemoglobin within the
IMH contains causes shortening of all MR relaxation pa-
rameters in a similar way to myocardial iron overload.
IMH represents severe reperfusion injury in acute myocar-
dial infarction and has the potential to be used as a surro-
gate marker to assess the effects of preventive strategies to
reduce this. Pedersen used T1-weighted inversion reco-
very, T2-STIR (short tau inversion recovery) and T2* se-
quences to assess myocardial damage in a porcine model
of myocardial infarction [124]. The CMR images were
compared with the area of IMH at histology. Despite rela-
tively wide limits of agreement, the authors found that the
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sitivity when compared to T2-STIR and T2* sequences for
the detection of IMH. However, further work may be
needed before this can be used as a reliable surrogate end-
point for clinical trials [125].
CMR of microvascular obstruction and hemorrhage in
myocardial infarction
Katherine Wu’s excellent review of MVO and hemorrhage
in myocardial infarction summarized the underlying
pathophysiology behind this common clinical problem as
well as the CMR techniques used for its diagnosis, the
clinical implications, and future directions needed for im-
proving the understanding of the issues involved [126].
Semi-automatic segmentation of myocardium at risk in
T2-weighted cardiovascular magnetic resonance
Quantification of the area at risk (the region of viable but
ischemic myocardium) after an acute coronary syndrome
can be used to determine the amount of myocardial sal-
vage following intervention. In a similar way to the assess-
ment of late enhancement, there is debate as to the best
measurement technique. As a result, studies have relied
upon either manual delineation or threshold methods
(using 2 standard deviations from remote regions, full
width half maximum intensity, or Otsu’s method) but
these techniques have inherent limitations. Sjögren et al.
report an automatic segmentation algorithm for quantifi-
cation of area at risk (AAR) which defines the continuous
region most likely to represent AAR by estimating the in-
tensities of normal myocardium and AAR with an expect-
ation maximization algorithm, restricting the AAR region
according to an a priori model of the maximal expected
extent for the culprit artery [127]. In a study population of
47 STEMI patients, results were favourable with a good
agreement between the automatic segmentation method
and AAR assessed using manual delineation and all three
threshold methods. Thus, this may represent a promising,
objective method for standardized quantification of area at
risk using T2-weighted sequences.
Non-contrast T1-mapping detects acute myocardial
edema with high diagnostic accuracy: a comparison to
T2-weighted cardiovascular magnetic resonance
Although T2-weighted sequences have been widely used to
assess myocardial oedema, quantitative T1-mapping is also
sensitive to changes in free water content. The Oxford
group in collaboration with Matthias Friedrich in Calgary
compared 21 healthy controls and 21 patients with
Takotsubo cardiomyopathy or acute regional myocardial
edema without infarction. Wall motion, myocardial T1
values (ShMOLLI T1) and T2 signal intensity ratio relative
to both skeletal muscle and remote myocardium (with both
dark-blood T2-STIR and bright-blood ACUT2E) werecompared on CMR scans performed at 1.5T within 7 days
of the index event [128]. Receiver operator characteristics
(ROC) analysis showed that T1-mapping had a significantly
larger area-under-the-curve (AUC = 0.94) compared to
T2-weighted methods, whether the reference ROI was
skeletal muscle or remote myocardium (AUC = 0.58-0.89;
p < 0.03). A T1 value of >990 ms most optimally differenti-
ated segments affected by edema from normal segments,
with a sensitivity and specificity of 92%. Non-contrast
T1-mapping therefore may have a role as a complementary
technique to T2-weighted imaging for assessing myocardial
edema, such as quantifying area-at-risk and diagnosing
myocarditis.
Cardiovascular magnetic resonance of myocardial edema
using a short inversion time inversion recovery (STIR)
black-blood technique: diagnostic accuracy of visual and
semi-quantitative assessment
In response to reportedly variable image quality associated
with STIR sequences for the detection of myocardial
oedema, the Leeds group studied image quality and diag-
nostic performance of STIR using a set of pulse sequence
parameters dedicated to edema detection [129]. STIR im-
ages were evaluated acutely in STEMI patients for image
quality as well as for presence and extent of myocardial
hyper-intensity, with both visual and semi-quantitative
(threshold-based) analysis. The extent of late enhance-
ment was used as a reference standard for localization and
extent of myocardial necrosis (acute) or scar (chronic).
STIR image quality was rated as diagnostic in 99.5% of
cases and reliably detected infarcted segments in the acute
stage both on visual and semi-quantitative assessment.
STIR also accurately differentiated acutely from chronic-
ally infarcted segments with a specificity of 99% by visual
assessment and 97% by semi-quantitative assessment and
with a sensitivity of 95% by both methods. The extent of
hyper-intense areas on acute STIR images was 85% larger
than those on LGE images, with a larger myocardial sal-
vage index in reperfused than in non-reperfused infarcts
(p = 0.035). The group concluded that with appropriate
pulse sequence settings, T2-STIR is accurate in detecting
acute myocardial infarction (MI) and distinguishing acute
from chronic MI with both visual and semi-quantitative
analysis. However, due to its unique technical characteris-
tics, STIR should be regarded as an edema-weighted ra-
ther than a purely T2-weighted technique.
Cardiovascular magnetic resonance by non contrast
T1-mapping allows assessment of severity of injury in
acute myocardial infarction
In a paper closely related to the group’s previous ma-
nuscript on the assessment of myocardial oedema,
Dall’Armellina et al. reported the utility of pre-contrast
T1-mapping for delineating the extent of ischemic
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cardial infarction [130]. In 41 patients with acute myocar-
dial infarction (78% STEMI), T2W, T1-mapping and LGE
sequences were performed using 3T CMR both 12–48
hour after chest pain onset and at 6 months. Patients with
STEMI underwent primary PCI prior to CMR. It was
found that the variability of T1 measurements was signifi-
cantly lower compared to T2W sequences and in terms of
diagnostic performance, T1-mapping was superior to
T2W imaging in NSTEMI. In STEMI patients, it was at
least as good as T2W-CMR. The myocardial salvage index
derived from acute T1-mapping and 6M LGE was no dif-
ferent to the one derived from T2W images (P = 0.88).
Furthermore, the likelihood of improvement in segmental
function at 6 months decreased progressively as acute T1
values increased (P < 0.0004). It therefore appears that T1-
mapping might become an important complementary
technique to LGE and T2W for identification of reversible
myocardial injury and prediction of functional recovery in
acute MI.
Multicontrast delayed enhancement (MCODE) improves
detection of subendocardial myocardial infarction by late
gadolinium enhancement cardiovascular magnetic
resonance: a clinical validation study
MultiContrast Delayed Enhancement (MCODE) imaging
simultaneously provides a T2-weighted image with a phase
sensitive inversion recovery (PSIR) LGE image and can be
used to discriminate subendocardial infarction more
clearly. With standard LGE techniques, this can be chal-
lenging especially if there is poor contrast between the
blood pool and the infarct itself. Bandettini and colleagues
reported a prospective comparison between MCODE and
standard PSIR LGE imaging in 73 patients referred for
vasodilator stress perfusion by targeted, repeat imaging of
slice locations [131]. MCODE had similar specificity com-
pared to LGE but demonstrated better sensitivity com-
pared to LGE performed early and immediately before
and after the MCODE (p = 0.008 and 0.02 respectively).
While both PSIR LGE and MCODE were good at identify-
ing MI, MCODE identified more subendocardial infarcts
and a larger number of infarcted sectors than PSIR LGE
alone. Thus the simultaneous acquisition of T1 and T2-
weighted images improved the differentiation of blood
pool from the enhancement associated with subendo-
cardial MI and may prove very useful in clinical practice.
In vivo chronic myocardial infarction characterization by
spin locked cardiovascular magnetic resonance
Characterization of infarcted myocardium using CMR
typically relies on late gadolinium enhancement (LGE)
techniques as T1 and T2 weighted imaging is relatively
insensitive to chronic infarction without the use of a
paramagnetic contrast agent. Witschey et al. proposedthat T1ρ-weighted rotating frame CMR techniques could
be used to measure infarct size in the absence of a con-
trast agent due to the relatively large change in T1ρ relax-
ation time between scar and myocardium [132]. In a
porcine infarct model, T1ρ-weighted imaging was perfor-
med with a B1 = 500 Hz spin lock pulse on a 3 T clinical
MR scanner. T1ρ relaxation time maps were computed
from multiple T1ρ-weighted images at varying spin lock
durations. There was no difference in infarct size mea-
sured by high resolution late enhancement, T1ρ CMR or
optical planimetry in the explanted hearts following sacri-
fice. T1ρ relaxation times were 91.7 ms in the infarct and
47.2 ms in remote myocardium, enabling good discrimin-
ation between infarcted and normal myocardium. The au-
thors concluded that T1ρ CMR has the potential for
visualizing MI without the need for exogenous contrast
agents in a wide range of clinical cardiac applications.
Cardiovascular magnetic resonance characterization of
peri-infarct zone remodeling following myocardial
infarction
At the edges of a region of infarcted myocardium, the
peri-infarct zone (PIZ) contains a mixture of viable and
non-viable myocytes, the extent of which is associated
with susceptibility to arrhythmia (ventricular tachycar-
dia) and adverse cardiac outcomes. In this study, the
group attempted to characterize early temporal changes
in scar morphology and regional function in the PIZ.
Custom signal density threshold algorithms, based on
remote myocardium, were applied to define infarct core
and peri-infarct zone in minipigs with reperfused, ante-
roseptal infarcts [133]. The authors found that, after the
initial edema following reperfused MI subsides, the
peri-infarct zone remains dynamic and decreases in
mass. The tensile forces in the PIZ also change as the in-
farct zone expands and thins out (with regional circumfer-
ential strain increasing between the infarct scar and the
PIZ at 30 days post-MI). It is therefore hypothesised that
remodelling characteristics of the PIZ might provide mech-
anistic insights into the development of life-threatening
arrhythmias and sudden cardiac death post-MI.
Infarct healing is a dynamic process following acute
myocardial infarction
Following on from the previous paper, the dynamic na-
ture of infarct healing in terms of the amount, the rate
and duration was assessed in 66 patients enrolled follow-
ing reperfusion for acute STEMI [134]. Mean infarct size
decreased progressively from baseline (within 1 week of
the acute event) to 4 months and 14 months, the largest
infarcts having the greatest absolute decrease in mass.
The percent reduction of infarct mass was independent
of initial infarct size with a 32% decrease in infarct mass
between acute necrosis and 4 months (p < 0.01) and an
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14 months (p < 0.01). This confirms that infarct healing
is a continuous process after reperfusion for STEMI and
that therefore, both decisions based on and interventions
performed to reduce infarct size, must take into consid-
eration the time frame of measurement.
Remodeling after acute myocardial infarction: mapping
ventricular dilatation using three dimensional CMR image
registration
O’Regan et al. used 3D co-registration of CMR images to
assess the long-term effects of ischemia-reperfusion injury
on left ventricular structure in 46 patients following pri-
mary PCI for acute STEMI [135]. Patients were scanned
within 7 days and again at one year. Localised LV wall
changes were assessed using intensity-based similarities to
track the structural changes in the heart between baseline
and follow-up. As expected, local LV remodeling was
greater within infarcted myocardium than in non-
infarcted myocardium and was directly related to the
transmural extent of infarction with greatest wall dilata-
tion observed when infarct transmurality exceeded 50%.
In addition, infarct remodeling was more severe when
microvascular obstruction was present but only a modest
dilatation was observed within non-ischemic myocardium.
This technique therefore has potential for assessing dy-
namic regional changes in ventricular structure in relation
to therapeutic interventions.
Heme arginate improves reperfusion patterns after
ischemia: a randomized, placebo-controlled trial in
healthy male subjects
In this study, 3T blood oxygen level dependent (BOLD)
functional MRI was used to assess whether heme arginate
could prevent ischemia-reperfusion injury in the calf mus-
cles of 12 healthy male subjects [136]. BOLD can measure
changes in tissue oxygenation with a high spatial and tem-
poral resolution. Heme arginate (1 mg/kg body weight) or
placebo was infused 24 hours prior to a 20 minute period
of leg ischemia induced by a thigh cuff. The peak reactive
hyperemia signal of the calf muscles was significantly in-
creased and occurred earlier after heme arginate than
placebo. It is therefore possible that heme arginate may
protect tissue against ischemia-reperfusion injury. The
underlying mechanism is via induction of heme oxygenase-
1. MR is able to provide this information using very simple,
economical equipment both for calf muscle exercise within
the magnet bore and for models of ischemia.
Assessment of distribution and evolution of mechanical
dyssynchrony in a porcine model of myocardial infarction
by cardiovascular magnetic resonance
Cine, tagging and late gadolinium sequences were used in
this study to characterize cardiac morphology, location andextent of MI, and regional mechanics in 6 pigs pre- and
post-MI [137]. This was correlated with electro-anatomic
mapping (EAM) performed within 24 hrs of CMR and
prior to sacrifice. The authors found a significant decrease
in global circumferential strain post MI with no significant
change in peri-infarct and MI segments between early and
late time-points (9 ± 2 vs. 22 ± 10 days). Time to peak
strain (TTP) was significantly longer and its standard
deviation greater in infarcted, compared to normal and
peri-infarct segments, both early and late post-MI. EAM
revealed late electrical activation and greatly diminished
conduction velocity in the infarct when compared to peri-
infarct and remote myocardium. From these data, the au-
thors conclude that mechanical dyssynchrony occurs early
after MI and is the result of delayed electrical and mech-
anical activation in the infarct. Mechanical dyssynchrony
post-MI is associated with adverse LV remodelling and in-
creased mortality. Interventions to minimise infarct size
may therefore have beneficial effects on survival.
A CMR study of the effects of tissue edema and necrosis
on left ventricular dyssynchrony in acute myocardial
infarction: implications for cardiac resynchronization
therapy
CMR is known to have utility in guiding resynchronization
therapy [138,139]. In this study, a novel 3D tagging se-
quence was used to produce the ‘CURE’ index (circumfer-
ential uniformity ratio estimate; a value of 1 = complete
synchrony) in 22 patients following successful PCI. Edema
(using T2-weighted images) and necrosis (using late en-
hancement) were quantified to determine the region of
salvaged myocardium (area-at-risk minus necrosis) [140].
The authors found that in the acute phase, the extent of
edema correlated with dyssynchrony, while extent of ne-
crosis showed only a borderline correlation. PCI resulted
in salvaged myocardium of 27 ± 14%. LV dyssynchrony
(using the CURE index) improved at 4 months from
0.91 ± 0.05 to 0.94 ± 0.03 (p < 0.004). At 4 months, edema
was absent and LV scar percentage had reduced slightly.
Although LV dyssynchrony was closely related to the ex-
tent of edema in the acute phase of infarction, necrosis
was found to be a poor predictor of acute dyssynchrony.
However, reduction in intraventricular dyssynchrony dur-
ing infarct healing was predicted by both the extent of
edema and necrosis in the acute phase. This study is a fur-
ther demonstration of the utility of CMR for assessing sur-
rogate markers of adverse outcome in acute infarction.
Thrombus aspiration during primary percutaneous
coronary intervention is associated with reduced
myocardial edema, hemorrhage, microvascular
obstruction and left ventricular remodeling
It is established that MVO and hemorrhage portend an
adverse clinical outcome and it therefore follows that
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improved prognosis. In this retrospective study, Zia
showed that coronary thrombus aspiration (TA) during
primary percutaneous coronary intervention (PCI) was
associated with reduced myocardial edema, myocardial
hemorrhage, left ventricular remodeling and incidence
of MVO after STEMI (assessed by T2, T2*, steady-state
free precession cine and contrast-enhanced T1-weighted
inversion recovery gradient-echo sequences respectively)
[141]. Sixty patients, enrolled after primary PCI, under-
went CMR scans at 48 hours and 6 months. They were
retrospectively stratified into 2 groups: those that received
TA versus those that did not. At 48 hours, infarct segment
T2 was lower (p = 0.022), indicative of less edema, infarct
segment T2* was higher (p = 0.007), suggesting a lesser
degree of myocardial hemorrhage and the incidence of
MVO was lower (p = 0.013) in the TA group. In this same
group at six months, the LV end-diastolic volume index
and LV end systolic volume index were lower (p = 0.013
and p = 0.008 respectively) and the infarct segment systolic
wall thickening was higher (p = 0.003). Although this intui-
tively appears a very positive result, a degree of caution is
needed in interpreting the results at face value. In a retro-
spective subgroup analysis of the HORIZONS-AMI study,
the use of thrombus aspiration in STEMI patients un-
dergoing primary PCI was associated with improved
ST-segment resolution at discharge, but not with any dif-
ference in final coronary artery flow, myocardial perfusion
(assessed by myocardial perfusion grade at cardiac cath-
eterisation) or major adverse cardiac events (MACE) [142].
Gadolinium use in CMR
The power of CMR is in no small part due to the addi-
tive information that can be gained by the administra-
tion of gadolinium based contrast agents (GBCAs), and
these are being applied in new situations especially the
atria [143]. There is now general awareness of the rare
but potentially serious complication of nephrogenic sys-
temic fibrosis (NSF) observed following administration
of some earlier GBCAs, notably in the presence of sig-
nificant renal impairment. This had led to guidelines
regarding the use of these agents.
Gadolinium in pediatric cardiovascular magnetic
resonance: what we know and how we practice
No GBCA is currently approved for use in children
under the age of 2 years. This manuscript reports the re-
sults of the 70 replies to a worldwide survey of GBCA
use by cardiac imagers with paediatric experience, with
an emphasis on studying the use of GBCAs in neonates
[144]. The predominant agent used was gadopentetate
dimeglumine (by 49% of respondents). Choice was prin-
cipally determined by availability with some conside-
ration to licensed indications above side effect profile orimage quality. Use of GBCAs in neonates by respon-
dents was widespread (93%) with 79% using agents in
neonates of <1 week of age. No respondents adminis-
tered GBCAs if the estimated glomerular filtration rate
was below 30 ml/min/1.73m2. Nausea or vomiting were
reported as common side effects by 60% of respondents.
The manuscript supports awareness by responding car-
diac imagers of the immature renal function and physio-
logical differences in paediatric patients that places them
at risk of NSF. It also highlights the paucity of data re-
garding use of such agents in the neonatal and paediatric
populations, and the resulting hindrance to licensing
and guideline formulation.
Gadolinium-enhanced cardiovascular magnetic resonance:
administered dose in relationship to united states food
and drug administration (FDA) guidelines
Growing awareness of the relationship between gadolin-
ium exposure and the development of NSF led to revised
label warnings for GBCAs in 2008. The results of a
meta-analysis of gadolinium dosing regimes in 233 peer-
reviewed studies published between 2004 and 2010 where
gadolinium was employed for CMR in a total of 19,934 pa-
tients are reported in this manuscript [145]. In 199 of the
studies, the indication for gadolinium administration was
in the assessment of late myocardial enhancement. Almost
half of the studies (114) used gadopentetate dimeglumine.
The analysis shows that in the published literature gado-
linium is typically administered at higher than label-
recommended doses (with median doses for each year
0.15 mmol/kg or more) and that no significant dose re-
duction (P > 0.05) was seen following FDA black box
warnings. The manuscript highlights the need for clinical
trials to determine the most appropriate doses of gadoli-
nium for CMR studies.
Minimizing risk of nephrogenic systemic fibrosis in
cardiovascular magnetic resonance
Awareness of NSF and the pre-requisite substrate of se-
vere renal impairment for developing this condition, to-
gether with more stable gadolinium chelates has created
a somewhat self-limiting problem. Nevertheless, this re-
view elegantly provides an overview of what remains a
relevant issue, notably with respect to maintaining the
safe use of GBCAs [146]. The ongoing prevention of
cases remains important given there is no cure for NSF.
The review describes the current understanding of NSF
pathochemistry, pathogenesis and treatment options,
with an emphasis on translating the various guidelines
into clinical practice so as to negate the risk of NSF.
Myocardial mechanics
Measuring cardiac function is a fundamental for CMR.
Myocardial tagging has recently been reviewed [147],
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[148,149] and animals. [150,151] feature tracking has be-
come an area of active interest with development of sim-
ple to use software that can be used post-hoc on simple
cines, however the lack of validation remains an issue.
The papers pursue novel aspects of cardiac function.
Quantification of biventricular myocardial function using
cardiac magnetic resonance feature tracking, endocardial
border delineation and echocardiographic speckle
tracking in patients with repaired tetralogy of Fallot and
healthy controls
Feature tracking (FT) post processing of routinely ac-
quired SSFP cines is an appealing approach to quantifica-
tion of myocardial strain, and has been used during
dobutamine stress [152]. This study applied it to the RV as
well as the LV, which is of potential interest as CMR al-
lows more complete RV wall coverage than echocardiog-
raphy [153]. While FT software provides readouts of
regional strain, these have yet to be validated. In this study,
even the inter-observer reproducibility of regional FT ana-
lyses of the same cine acquisitions appeared suboptimal.
Inter-study reproducibility was not investigated. Global
measures of strain by FT showed more encouraging levels
of inter-observer reproducibility and of agreement with
comparable measures by echocardiographic speckle track-
ing in the same patients. Interestingly, however, the au-
thors’ own endocardial boundary tracking software, which
they programmed using Matlab, gave comparable levels of
reproducibility and agreement, implying that measures of
global circumferential strain by FT may represent little
more than measures of diastolic-systolic change of cavity
boundary length.
Inter-study reproducibility of cardiovascular magnetic
resonance myocardial feature tracking
This paper reported the inter-study variation of global and
regional strain as measured by feature tracking analyses of
CMR SSFP cines in 16 healthy volunteers [154]. Although
this was not attempted in patients with ventricular dys-
function, and was not compared here with any reference
method such as tagging, inter-study reproducibility is
clearly more clinically relevant than inter-observer repro-
ducibility, which says little about the reproducibility in
practice of an image post-processing method. The inter-
study reproducibility of different strain analyses varied.
The coefficient of variation (CV) of global assessment by
FT of circumferential strain in short axis slices was 20.3%,
compared with 38% for segmental analysis of the same.
The least reproducible segmental measure was that of
right ventricular longitudinal strain (CV 60%) whilst the
least reproducible global measure was that of radially di-
rected strain measured from 4-chamber long axis cines
(CV 33.3%). CMR FT may have potential for quantitativewall motion analysis, for example in clinical trials but,
given the coefficients of variation found in volunteers,
users should clearly interpret comparable FT measure-
ments individual patients with caution.
Undersampled cine 3D tagging for rapid assessment of
cardiac motion
This study reported k-t undersampled cine 3D tagging in
conjunction with k-t principal component analysis (PCA)
reconstruction for single breath-hold acquisitions of
multidirectional strain of the whole heart [155]. The per-
formance of such undersampled methods was investigated
using computer simulations and in-vivo measurements in
8 healthy subjects and 5 patients with myocardial infarc-
tion. In patients, peak circumferential shortening was re-
duced in regions with late gadolinium enhancement. The
undersampled approach allowed reduction in acquisition
time of whole-heart tagging which facilitated quantifica-
tion of shortening, rotation and torsion of the left ventricle
without adding significant errors compared to previous
3D tagging approaches.
Evaluation of left ventricular torsion by cardiovascular
magnetic resonance
This paper reviews current clinical applications LV torsion
measurements by CMR, showing how torsion can give in-
sights into LV mechanics and the influence of LV geo-
metry and myocyte fiber architecture on cardiac function
[156]. It offers recommendations for CMR measurement
protocols, attempts to stimulate standardization of torsion
calculation, and suggests areas for future research.
Subendocardial contractile impairment in chronic
ischemic myocardium: assessment by strain analysis of 3T
tagged CMR
This study reported measurements of myocardial strain
in the subendocardial and epicardial layers of the LV by
resting tagged CMR at 3T in 12 patients with severe
chronic coronary artery disease who had been scheduled
for coronary artery bypass grafting [157]. Myocardial
segments were divided into stenotic and non-stenotic by
invasive coronary angiography, and ischemic and non-
ischemic segments by stress myocardial perfusion scin-
tigraphy. Analyses showed lower circumferential stain in
stenotic than non-stenotic segments, without significant
differences between the two groups for strain of the epi-
cardial layer. They also showed impairment of circum-
ferential strain in the subendocardial layer of chronically
ischemic myocardium at rest.
Mapping right ventricular myocardial mechanics using 3D
cine DENSE cardiovascular magnetic resonance
This study reports measurements of RV mechanics by
whole heart three dimensional cine displacement encoding
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teers [158]. The inflow region showed lower peak strains
than the apical and outflow regions, and the time to peak
strains suggested RV mechanical activation in the order:
inflow, outflow, mid, then apex. The techniques used may
have clinical utility for assessing altered RV mechanics in
disease.
Three-dimensional regional strain analysis in porcine
myocardial infarction: a 3T magnetic resonance tagging
study
This study set out to investigate the incremental value of
3D relative to 1D or 2D harmonic phase analyses of
strain by CMR in the assessment of viability in a porcine
model of infarction [159]. The 3D strain information
distinguished infarcts and their neighboring regions
from healthy myocardium. The 3D interrogation of con-
tractility was found to give incremental diagnostic accur-
acy in delineating the dysfunctional and nonviable
myocardium relative to 1D or 2D methods. The infarct
neighboring regions were the major beneficiaries of the
more comprehensive, 3D assessment of regional strain.
Left ventricular volumes and motion
Given increasing availability and uptake of CMR, it is ever
more important to determine the appropriate application
of CMR derived values to clinical use. Although there is
correlation between ejection fraction measure by CMR
and echocardiography, the values are not interchangeable.
Consequently, where an evidence base has been estab-
lished in one modality, the threshold value cannot ne-
cessarily accurately and reliably be transferred across
modalities. Additional CMR derived parameters continue
to be generated, increasingly from the acquisition of 3D
data sets. An emphasis on expanding the collection of ro-
bust prospectively acquired multi-centre multi-vendor sci-
entific data is required to generate appropriate clinical and
prognostic thresholds for CMR derived parameters. Al-
though the fundamental techniques for measuring ven-
tricular function and mass using the contiguous parallel
short axis slices techniques are well established, there are
continuing reports of variants of the basic technique
[160], and extension of its application to all 4 cardiac
chambers [161,162]. The excellent reproducibility of left
ventricular mass measurements makes CMR valuable in
studies of drug efficacy [163].
Potential clinical impact of cardiovascular magnetic
resonance assessment of ejection fraction on eligibility
for cardioverter defibrillator implantation
This retrospective single centre study of 52 patients high-
lights the clinically important discrepancy between left
ventricular ejection fraction (LVEF) as measured by CMR
compared to echocardiography and investigates thepotential impact of applying the echo derived selection cri-
teria for ICD implantation to CMR derived data [164].
The use of CMR derived LVEF against the echocardio-
graphic derived threshold of 35% would have resulted in
21% of patients being reclassified with regards to ICD eli-
gibility. Of further note, CMR identified the presence of
LV thrombus in 6 of the patients under consideration for
ICD implantation, whereas echocardiography only identi-
fied 1 of these. The argument for CMR to be the imaging
modality of choice in assessing device suitability is
strengthened by the superior reproducibility of CMR com-
pared to echocardiography, let alone its potential for
viability and scar imaging. Large scale multi-centre pro-
spective studies are required to better define the clinical
evidence base for CMR parameters further.
Late gadolinium enhancement by cardiovascular
magnetic resonance is complementary to left ventricle
ejection fraction in predicting prognosis of patients with
stable coronary artery disease
In this study, 376 patients with stable coronary artery dis-
ease were followed up prospectively for 38 ± 21 months to
assess the incremental prognostic value of late gadolinium
enhancement (LGE) as an adverse prognostic factor above
conventional risk factors including LVEF [165]. LGE and
LVEF were both robust independent non-invasive markers
of prognosis with respect to the primary end point of all
cause mortality and hospitalisation for a new diagnosis of
heart failure (HR: 13.61 for LGE ≥ 45% of LV mass; and
12.34 for LVEF ≤ 30%; p < 0.0001). Furthermore LGE en-
hanced risk stratification when incorporated into a multi-
variate model.
A quantitative comparison of regional myocardial motion
in mice, rabbits and humans using in-vivo phase contrast
CMR
This manuscript addresses the important issue of how
closely small animal myocardial motion resembles and
replicates human cardiac physiology and pathology
[166]. Using phase contrast CMR to assess regional 3D
left ventricular motion with high temporal resolution in
18 mice, 8 rabbits and 9 humans, subtle but significantly
different regional myocardial motion patterns were ob-
served between and within species. Given the prominent
role of genetically modified animal models in resear-
ching human cardiovascular disease, these differences
must be considered.
Volumetric motion quantification by 3D tissue phase
mapped CMR
This manuscript describes extensive quantification of
myocardial motion of the entire left ventricle from 3D
tissue phase mapped (TPM) CMR in 12 healthy volun-
teers and 2 patients [167]. Having shown in a previous
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celerate 2D TPM, here the authors use SENSE to facilitate
3D acquisitions with isotropic pixel size. They propose
that this facilitates more detailed analysis of LV motion
which may enhance patient selection for cardiac resyn-
chronisation therapy. It was possible to determine velocity,
torsion, rotation and strain derived parameters from the
3D-TPM data, and also identify abnormal wall motion in
the patients compared to the healthy subjects using these.
Additional data will be required to more fully elucidate
the clinical prognostic value of these parameters.
Varia
There are always papers which defy simple catego-
rization. This section pulls together such varia which in-
cludes society reports [168], and novel [169], or unusual
techniques [170-172].
Review of journal of cardiovascular magnetic resonance
2011
The review of JCMR papers in 2011 [173], and the
President's page [174], were highly accessed which the
editors consider reflects the interest of the readership in
having a review article collating the year's papers bring-
ing together the articles into thematic headings.
Assessment of MRI issues at 3-tesla for metallic surgical
implants: findings applied to 61 additional skin closure
staples and vessel ligation clips
Metallic skin closure staples and vessel ligation clips were
assessed at 3 Tesla for magnetic field interactions, heating,
and artifacts in this paper [175]. MRI-related heating was
assessed by placing each implant in a gelled-saline-filled
phantom with MRI performed using a transmit/receive RF
body coil at an MR system reported, whole body averaged
SAR of 2.9-W/kg for 15-min. Artifacts were characterized
using T1-weighted, SE and GRE pulse sequences. Each
surgical implant showed minor magnetic field interactions
(20- and 27-degrees, which is acceptable from a safety
consideration). Heating was not substantial (highest
temperature change, ≤ 1.6°C). Artifacts may create issues
if the area of interest is in the same area or close to the re-
spective surgical implant.
Cost evaluation of cardiovascular magnetic resonance
versus coronary angiography for the diagnostic work-up
of coronary artery disease: application of the european
cardiovascular magnetic resonance registry data to the
german, united kingdom, swiss, and united states health
care systems.
CMR has favorable characteristics for diagnostic evalu-
ation and risk stratification of patients with known or
suspected CAD. CMR utilization in CAD detection is
growing fast. However, data on its cost-effectiveness are
scarce. The goal of this study was to compare the costs oftwo strategies for detection of significant coronary artery
stenoses in patients with suspected coronary artery disease
(CAD): 1) Performing CMR first to assess myocardial is-
chemia and/or infarct scar before referring positive pa-
tients (defined as presence of ischemia and/or infarct scar
to coronary angiography (CXA) versus 2) a hypothetical
CXA performed in all patients as a single test to detect
CAD [176]. A subgroup of the European CMR pilot regis-
try was used including 2,717 consecutive patients who
underwent stress-CMR. From these patients, 21% were
positive for CAD (ischemia and/or infarct scar), 73% nega-
tive, and 6% uncertain and underwent additional testing.
The diagnostic costs were evaluated using invoicing costs
of each test performed. Costs analysis was performed from
a health care payer perspective in German, United King-
dom, Swiss, and United States health care settings. In the
public sectors of the German, United Kingdom, and Swiss
health care systems, cost savings from the CMR-driven
strategy were 50%, 25% and 23%, respectively, versus out-
patient CXA. If CXA was carried out as an inpatient pro-
cedure, cost savings were 46%, 50% and 48%, respectively.
In the United States context, cost savings were 51% when
compared with inpatient CXA, but higher for CMR by 8%
versus outpatient CXA. The authors conclude that the use
of CMR should be encouraged as a management option
for patients with suspected CAD.
Monocenter feasibility study of the MRI compatibility of the
evia pacemaker in combination with safio s pacemaker lead
The number of MR conditional pacemakers is increas-
ing, which has been reviewed recently [177], and reports
are now emerging of performance of imaging of the
heart by MR in their presence [178]. The purpose of this
study was to evaluate the feasibility of the magnetic res-
onance (MR) conditional pacemaker (PM) system (Evia
SR-T and DR-T with Safio S leads) under MR conditions
[179]. Patients with standard PM indications and Evia
PM were eligible for enrollment in this single center
prospective non-randomized pilot study. Patients under-
went MR of the brain and lower lumbar spine at 1.5
Tesla. Atrial (RA) und ventricular (RV) lead parameters
(sensing, pacing threshold [PTH], pacing impedance)
were assessed immediately before (baseline follow-up
[FU]) and immediately after MRI (1st FU), after 1 month
(2nd FU) and 3 months (3rd FU). The effect of MR on
serious adverse device effect (SADE) free-rate, on atrial
and ventricular sensing (AS/VS; mV) and atrial (RA)
and ventricular (RV) pacing thresholds (PTH; V/0.4 ms)
were investigated between baseline and 2nd FU. Data of
30 patients (female 12 [40%], age 73 ± 12 years, dual
chamber PM 15 [50%]) were included in this analysis.
No MR related SADE occurred. Lead measurements
were not statistically different between the baseline FU
and the 2nd FU (AS/VS at baseline 3.2 ± 2.1/15.0 ± 6.0,
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PTH at baseline 0.68 ± 0.18/0.78 ± 0.22, at 2nd FU
0.71 ± 0.24/0.78 ± 0.22; p = ns). The presence of the
permanent pacemakers led to MR imaging artifacts on
diffusion weighted sequences of the brain, but did not
affect other sequences (e.g. FLAIR and T2 weighted
spin-echo images). The authors conclude that the use of
the MR conditional Evia PM in a MR environment under
predefined conditions is feasible.
Cardiovascular magnetic resonance physics for clinicians:
part II
This is the second of 2 reviews [180], covering the essen-
tial aspects of CMR physics in a way that is understand-
able and relevant to clinicians using CMR in their daily
practice. Starting with the basic pulse sequences and con-
trast mechanisms described in part I, it briefly discusses
further approaches to accelerate image acquisition. It then
continues by showing in detail how the contrast behaviour
of black blood fast spin echo and bright blood cine gradi-
ent echo techniques can be modified by adding rf prepar-
ation pulses to derive a number of more specialised pulse
sequences. The simplest examples described include T2-
weighted oedema imaging, fat suppression and myocardial
tagging cine pulse sequences. Two further important de-
rivatives of the gradient echo pulse sequence, obtained by
adding preparation pulses, are used in combination with
the administration of a gadolinium-based contrast agent
for myocardial perfusion imaging and the assessment of
myocardial tissue viability using a late gadolinium en-
hancement (LGE) technique. These two imaging tech-
niques are discussed in more detail, outlining the basic
principles of each pulse sequence, the practical steps re-
quired to achieve the best results in a clinical setting and,
in the case of perfusion, explaining some of the factors
that influence current approaches to perfusion image ana-
lysis. The key principles of contrast-enhanced magnetic
resonance angiography (MRA) are also explained in detail,
especially focusing on timing of the acquisition following
contrast agent bolus administration, and current ap-
proaches to achieving time resolved MRA. Alternative
MRA techniques that do not require the use of an
endogenous contrast agent are summarised, and the
specialised pulse sequence used to image the coronary ar-
teries, using respiratory navigator gating, is described in
detail. The article concludes by explaining the principle
behind phase contrast imaging techniques which create
images that represent the phase of the MR signal rather
than the magnitude. It is shown how this principle can be
used to generate velocity maps by designing gradient
waveforms that give rise to a relative phase change that is
proportional to velocity and the choice of velocity encod-
ing range and key pitfalls in the use of this technique are
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